Drug
Novartis Investigational H5n1 Vaccine
Novartis Investigational H5n1 Vaccine: highest development phase Phase 3, developed by Novartis. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| Novartis Investigational H5N1 vaccine NCT02107807 | Phase 3 | Influenza, Human |
Latest
No recent events.
Follow Novartis Investigational H5n1 Vaccine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.